Pfizer/BioNTech Select North Alabama Research Center & Sister Site Medical-Affiliated Research Center for Phase 3 BNT162 COVID-19 Vaccine Trial

PfizerBioNTech Select North Alabama Research Center & Sister Site Medical-Affiliated Research Center for Phase 3 BNT162 COVID-19 Vaccine Trial

North Alabama Research Center (NARC) and a sister site called Medical-Affiliated Research Center of Huntsville gear up to conduct major COVID-19 vaccine clinical trials sponsored by the BioNTech and Pfizer partnership. The site operation and study is overseen by Tonya Pryor at the Athens and Huntsville-based research centers. These sites have partnered with Pfizer in the past, successfully, and hence were selected for this pivotal Phase 3 clinical trial investigating the safety and efficacy of mRNA-based BNT162.

U.S. Fed Gov. Makes Large BNT162 Purchase

This week, the companies announced that the U.S. government made an advanced purchase of 100 million doses for $1.95 billion if the vaccine, BNT162, in fact provides to be safe and efficacious and therefore ultimately approved by the U.S. Food and Drug Administration (FDA). Moreover, the U.S. federal government secured an option for up to 500 million more doses.

The Study in North Alabama

The next major clinical trial will involve 150 clinical research sites around the United States. The Phase 3 trial will come to North Alabama thanks to the sponsors selecting the two sites Ms. Tonya Pryor manages. As sites ac...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee